See related Prezista film-coated tab information |
|
Manufacturer |
Janssen |
Distributor |
Hong Kong: DKSH/Macau: Four Star |
Contents |
Darunavir |
Indications |
Treatment of HIV infection in antiretroviral treatment-experienced adult patients (in combination w/ ritonavir & other antiretroviral agents). |
Dosage |
Adult 18-65 yr 600 mg bd w/ ritonavir 100 mg bd. |
Administration |
Should be taken with food |
Contraindications |
Hypersensitivity. |
Special Precautions |
Patients w/ sulfonamide allergy & haemophilia. Liver disease. May exacerbate diabetes & hyperglycemia. Elderly, childn. May impair ability to drive or operate machinery. Pregnancy & lactation. |
Adverse Drug Reactions |
Headache, diarrhoea, vomiting, nausea, abdominal pain, constipation, nasopharyngitis. Lipodystrophy.
View ADR Monitoring Form |
Drug Interactions |
Astemizole, terfenadine, midazolam, triazolam, cisapride, pimozide, ergot alkaloids, rifampicin, St. John's wort, protease inhibitors, lopinavir, saquinavir, antiarrhythmics, anticoagulants, anticonvulsants, Ca-channel blockers, clarithromycin, ketoconazole, itraconazole, voriconazole, dexamethasone (systemic), HMG-CoA reductase inhibitors, immunosuppressants, methadone, estrogen-based contraceptives, PDE-5 inhibitors, inhaled fluticasone propionate.
View more drug interactions with Prezista |
Pregnancy Category (US FDA) |
Category C: Either studies in animals have revealed adverse effects on the foetus (teratogenic or embryocidal or other) and there are no controlled studies in women or studies in women and animals are not available. Drugs should be given only if the potential benefit justifies the potential risk to the foetus. |
ATC Classification |
J05AE10 - darunavir ; Belongs to the class of protease inhibitors. Used in the systemic treatment of viral infections. |
Presentation/Packing |
Form |
Packing |
Photo |
Prezista film-coated tablet |
Prezista 300 mg |
Prezista 400 mg |
Prezista 600 mg |
|
|
Manufacturer: |
Janssen |
Distributor: |
Hong Kong: DKSH
Macau: Four Star
|
|
|
|